Breakthroughs in Treatments for Idiopathic Pulmonary Fibrosis

Article

With the approval of two new drugs for the treatment of IPF, patients who otherwise would have only had lung transplantation as a treatment option now have a new way to improve their quality of life.

With the approval of two new drugs for the treatment of IPF, patients who otherwise would have only had lung transplantation as a treatment option now have a new way to improve their quality of life.

At the 2014 annual meeting of the American College of Chest Physicians in Austin, TX, the drug approvals were a topic of considerable discussion. Steven Nathan, MD, FCCP, discusses some of the advances made and what work remains to help patients with this complex, hard-to-treat condition.

Related Videos
Heart Failure stock imagery. | Credit: Fotolia
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
Joel Gelfand, MD, MSCE: Phototherapy Utility in Psoriasis
Pediatric Hidradenitis Suppurativa Severity not Linked to Obesity
© 2024 MJH Life Sciences

All rights reserved.